Search results for: 'complex therapies'

Complexities in migration journeys form the key challenge for many end users in Australia, driven mainly by difficulties in migrating complex Big Data applications to the cloud. In addition, many enterprises now have heterogeneous environments consisting of legacy IT infrastructure and cloud-based applications, creating integration challenges in ma...

The Asia-Pacific cloud computing market is expected to grow at a CAGR of 28.4% during 2016–2022. Revenue grew 30.7% from 2015 to reach $11.34 billion in 2016. Cloud spending was dominated by Japan, Australia, and China in 2016. The key underlying theme across the markets is the increase in demand for managed cloud services. This arises due to Big D...

05 Feb 2021  |  Asia Pacific  |  Market Research

Increasingly Sophisticated Threat Landscape Drives the Uptake of Managed Security Services in APAC

Complex Business Environment and Insufficient Cybersecurity Make the Adoption of MSS a Top Technology Strategy

Infographics

×

Managed security service providers (MSSPs) offer managed security services (MSS) that help manage and monitor the security posture of their customers’ IT infrastructure. By using these services, client organizations are often able to reduce expenditure on either customer premises equipment (CPE) or in-house security specialists, and receive effecti...

Frost & Sullivan has recently completed a comprehensive analysis on the current and future strategic imperatives of game-changing Asia-Pacific (APAC) pharmaceutical companies. The analysis primarily focuses on the changing trends in the pharmaceutical industry with respect to drug research and development, manufacturing, supply chain, and marketing...

05 Apr 2023  |  Asia Pacific  |  Market Outlook

Asia-Pacific Pharmaceutical Industry Outlook, 2023

Disruptive Technology Adoption and Outsourcing Growth is Advancing Innovation in the Pharmaceutical Industry

Infographics

×

Asia-Pacific’s pharmaceutical market is forecast to record 4.2% growth from 2022 to 2027, with China and Japan dominating the market in terms of value. Generics dominate the regional markets based on volume, directly impacting innovator molecule uptake. Nevertheless, Asia-Pacific is establishing itself as a global innovation hub, with China, Japan,...

The healthcare market in Asia-Pacific (APAC) is expected to grow by 7.2% in 2019 due to the growth of smart hospitals and developments in the home care segment and medical tourism. This, in turn, has increased the demand for technology, innovative healthcare programmes, as well as drugs and medical devices based on advanced technology. Conventional...

A market outlook of the Cardiac Rhythm Management Devices covering China, Hong Kong, South Korea and Malaysia. This study includes the market drivers, restraints and forecasting for the pacemaker, implantable cardioverter defibrillators (ICDs), cardiac resynchronization therapy (CRT) devices and CRM leads. The forecast period of the study is from 2...

This study presents an overview of the Asia-Pacific infectious disease point-of-care testing (POCT) market with an emphasis on some of the key trends and growth opportunities that are shaping the market. The study highlights some of the emerging business models supporting the development and adoption of innovative diagnostic tests. The Asia-Pacif...

10 Jan 2018  |  Asia Pacific  |  Market Research

APAC Biosimilar Market, Forecast 2025

Patent Expiries, Defined Regulatory Pathways, and Escalating Healthcare Costs to Boost Growth

Infographics

×

Key Issues Addressed Key Benefits

Biosimilars is a massive opportunity; regardless of a slow start, the market will eventually be a huge business. As per Frost & Sullivan’s estimate, biologic drugs worth $70–$80 billion will lose exclusivity in the next 5 years globally and APAC’s contribution would be more than 20%. Countries in the region, such as India, China, and South Korea, o...